Special Issue "Cyclodextrins and Their Derivatives: A Basis for New Drug Formulations"
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 11290
Interests: hypertension; structure elucidation; nuclear magnetic resonance; spectroscopy; NMR spectroscopy; medicinal and pharmaceutical chemistry; molecular modeling; Raman spectroscopy; DSC; NMR structure elucidation
Interests: development of tumor-homing and tumor-responsive drug delivery vehicles as theranostics; drug formulations and prodrugs; development of imaging agents for visualizing and charting cellular compartments; pharmacokinetics (LC-MS, HPLC-based) and bioactivity evaluation; design and development of cancer diagnostics and theranostics; development of tumor-homing probes equipped with multimodal imaging agents (for MRI, in vivo near-infrared I & II optical imaging, and SPECT/PET probes)
Special Issues, Collections and Topics in MDPI journals
Special Issue in Molecules: Targeting Cancer Metabolism for the Development of Diagnostic, Therapeutic and Theranostic Agents
Special Issue in Molecules: Peptide Conjugate as Therapeutic, Diagnostic and Theranostic Agents
Interests: drug-protein binding; drug-cyclodextrins interaction, characterization and effect on drug solubility/dissolution/absorption; Development and in vitro-in vivo evaluation of novel dosage forms with optimized absorption (GI/nasal/pulmonary); PK/PD studies and dosage individualization
As Guest Editors, we would like to announce a Special Issue entitled “Cyclodextrins and their Derivatives. A Basis for New Drug Formulations”. This Special Issue will collect communications, research articles, and high-quality review papers in the research fields relating to cyclodextrins, cyclodextrin derivatives, and drug–cyclodextrin interactions, for application in drug formulation developments. We kindly encourage research groups working in various areas of pharmaceutical technology, biopharmaceutics, medicinal and pharmaceutical chemistry, and chemical biology to make contributions to this Special Issue involving, but not restricted to: trends in novel cyclodextrin/cyclodextrin derivatives development, drug–cyclodextrin interactions, applications for novel drug formulations, repurposing of known drug entities through the development of new dosage forms for different routes of administration, pulmonary, nasal, transdermal, etc., and evaluation in vitro/ex vivo/in vivo. In addition, researchers are encouraged to submit articles or reviews that include existing and new methodologies suitable for studying drug–cyclodextrin interactions. The molecular nature of these interactions is critical for rational drug design. Reviews outlining the advantages and disadvantages of existing formulations are also welcome. Furthermore, research articles and review papers on cyclodextrin design, development, and characterization for application in drug design are also suitable for this Special Issue.
Prof. Dr. Thomas Mavromoustakos
Prof. Dr. Andreas G. Tzakos
Prof. Dr. Georgia N. Valsami
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cyclodextrin design/development/characterization
- drug–cyclodextrin interactions/formulations
- analytical methodologies for drug–cyclodextrin interactions/structure elucidation
- in vitro/ex vivo/in vivo evaluation
- other routes of drug administration (nasal, pulmonary, transdermal, etc.)